Newborn Screening Market: Industry Expert View on Future Growth and Market Trends
Newborn screening tests measure several markers in an infant’s blood that can be either decreased or increased if an infant has certain diseases. The screening can detect over 50 different conditions, such as critical congenital heart defect (CCHD), hearing screening, sickle cell disease, and other conditions. At present, conditions such as cystic fibrosis, congenital hypothyroidism, phenylketonuria, and around 22 other metabolic conditions that affect protein or fat metabolism can be diagnosed via newborn screening tests. Major factors driving the newborn screening market growth include rising funding from government sectors for newborn screening, the rising burden of congenital diseases, and the increasing prevalence of newborn disorders. Additionally, the integration of machine learning and artificial intelligence in screening is likely to emerge as a significant future trend in the newborn screening market during the forecast period.
The newborn screening market is comprised of top players involving Medtronic Plc, PerkinElmer Inc, Waters Corp, Bio-Rad Laboratories Inc, LifeCell International Pvt Ltd, Zentech SA, Trivitron Healthcare, Masimo Corp, Natus Medical Inc, Baebies Inc, and MRC Holland BV. The companies have been implementing various strategies that have helped their growth and, in turn, brought about several breakthroughs and transitions in the industry. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the market players have also deployed several utilized inorganic strategies, including mergers & acquisitions, partnerships, and collaborations.
Below are the major growth strategies undertaken by the players operating in the global newborn screening market:
May-2022: Medtronic plc received U.S. Food and Drug Administration (FDA) granted 510(k) approval for the Nellcor OxySoft SpO2 sensor. The device is the first pulse oximetry sensor to use a silicone adhesive designed to protect fragile skin and improve repositionability and signal acquisition. This new sensor will help clinicians respond quickly with well-informed decisions for their critical care patients.
Jan-2021: PerkinElmer, Inc. has joined the European Alliance for Newborn Screening in Spinal Muscular Atrophy, also known as the SMA NBS Alliance. Founded by SMA Europe – an umbrella organization that brings together 21 patient and research organizations focused on spinal muscular atrophy (SMA) from 20 countries across Europe – the SMA NBS Alliance has two primary objectives: to decrease the time it takes for a child to born with SMA to be diagnosed through newborn screening (NBS), and to assist patient advocacy groups in their efforts to accelerate the identification of such children, given that early diagnosis and treatment leads to better outcomes.
Jan-2020: LifeCell International, launched 'Genome-Scope' - a premier Genetic Diagnostic Test for newborns which assesses for thousands of early childhood-onset disorders. LifeCell offers this service within a turnaround time of just 10 days, which is twice as fast compared to the nearest offering - a vital time reduction for those who seek urgent diagnoses such as babies in the NICU.
About Us:
The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Chemicals and Materials.
The newborn screening market is comprised of top players involving Medtronic Plc, PerkinElmer Inc, Waters Corp, Bio-Rad Laboratories Inc, LifeCell International Pvt Ltd, Zentech SA, Trivitron Healthcare, Masimo Corp, Natus Medical Inc, Baebies Inc, and MRC Holland BV. The companies have been implementing various strategies that have helped their growth and, in turn, brought about several breakthroughs and transitions in the industry. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the market players have also deployed several utilized inorganic strategies, including mergers & acquisitions, partnerships, and collaborations.
Below are the major growth strategies undertaken by the players operating in the global newborn screening market:
May-2022: Medtronic plc received U.S. Food and Drug Administration (FDA) granted 510(k) approval for the Nellcor OxySoft SpO2 sensor. The device is the first pulse oximetry sensor to use a silicone adhesive designed to protect fragile skin and improve repositionability and signal acquisition. This new sensor will help clinicians respond quickly with well-informed decisions for their critical care patients.
Jan-2021: PerkinElmer, Inc. has joined the European Alliance for Newborn Screening in Spinal Muscular Atrophy, also known as the SMA NBS Alliance. Founded by SMA Europe – an umbrella organization that brings together 21 patient and research organizations focused on spinal muscular atrophy (SMA) from 20 countries across Europe – the SMA NBS Alliance has two primary objectives: to decrease the time it takes for a child to born with SMA to be diagnosed through newborn screening (NBS), and to assist patient advocacy groups in their efforts to accelerate the identification of such children, given that early diagnosis and treatment leads to better outcomes.
Jan-2020: LifeCell International, launched 'Genome-Scope' - a premier Genetic Diagnostic Test for newborns which assesses for thousands of early childhood-onset disorders. LifeCell offers this service within a turnaround time of just 10 days, which is twice as fast compared to the nearest offering - a vital time reduction for those who seek urgent diagnoses such as babies in the NICU.
About Us:
The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Chemicals and Materials.
Comments
Post a Comment